Botanix Pharmaceuticals Limited (AU:BOT)
Australian Market

Botanix Pharmaceuticals Limited (BOT) Financial Statements


Botanix Pharmaceuticals Limited Financial Overview

Botanix Pharmaceuticals Limited's market cap is currently ―. The company's EPS TTM is AU$-0.007; its P/E ratio is -49.32; Botanix Pharmaceuticals Limited is scheduled to report earnings on August 22, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 7.29MAU$ 21.55MAU$ 24.65MAU$ 4.70MAU$ 17.26M
Total AssetsAU$ 14.04MAU$ 21.95MAU$ 25.31MAU$ 5.20MAU$ 17.71M
Total DebtAU$ 122.41KAU$ 259.32KAU$ 420.62KAU$ 0.00AU$ 0.00
Net DebtAU$ -7.16MAU$ -21.30MAU$ -24.22MAU$ -4.70MAU$ -17.26M
Total LiabilitiesAU$ 5.89MAU$ 1.15MAU$ 1.67MAU$ 4.58MAU$ 1.43M
Stockholders EquityAU$ 8.15MAU$ 20.80MAU$ 23.64MAU$ 615.22KAU$ 16.28M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Botanix Pharmaceuticals Limited Earnings and Revenue History

Botanix Pharmaceuticals Limited Debt to Assets

Botanix Pharmaceuticals Limited Cash Flow

Botanix Pharmaceuticals Limited Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis